Geron Corporation

GERN Stock Healthcare Biotechnology
$1.48
-0.01 (-0.67%)
Price as of Sep 01, 2026 market close

Performance

1 Month
+15.6%
3 Months
+26.5%
YTD
+12.1%
1 Year
+5.7%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
63.8%
Largest decline max drawdown, since Aug 2025
-43.6%
Risk-adjusted return Sharpe ratio, 1-year
0.40

Own GERN?

See how GERN contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.